Sharesight20ASX weekly top 20 ASX trades – 6th October 2020
Disclaimer: The below article is for informational purposes only and does not constitute a product recommendation, or taxation or financial advice and should not be relied upon as such. Please consult with your financial adviser or accountant to obtain the correct advice for your situation.
In this Sharesight20ASX weekly snapshot of Sharesight users' 20 most traded stocks on the ASX, buy and sell trades were strongly led by Mesoblast (ASX: MSB), which saw plummeting share prices after being knocked back by the FDA for its blood cancer treatment. Trades were followed by a2 Milk (ASX: A2M) and the Vanguard Australian Shares ETF (ASX: VAS).
Top 20 ASX trades last week
Click on the image below to see the full Sharesight20ASX snapshot of the 20 most traded ASX shares during the period:
Subscribe to Sharesight20 snapshots
Did you know you can receive Sharesight20 trading snapshots by email automatically? Subscribe here to always get the latest data when it's released.
Track your investment portfolio with Sharesight
Get access to Sharesight20 insights like this by tracking your investment portfolio with Sharesight. Built for the needs of investors like you:
-
Track all your investments in one place, including stocks, mutual/managed funds, property, and even cryptocurrency
-
Get the true picture of your investment performance, including the impact of brokerage fees, dividends, and capital gains with Sharesight’s annualised performance calculation methodology
-
Run powerful reports built for investors, including Performance, Portfolio Diversity, Contribution Analysis and Future Income (upcoming dividends)
-
Run tax reports including Taxable Income (dividends/distributions), Capital Gains Tax (Australia and Canada), Traders Tax (Capital Gains for traders in NZ) and FIF foreign investment fund income reports (NZ)
Sign up for a FREE Sharesight account and get started tracking your investments today.
FURTHER READING
Sharesight vs. alternatives: Why investors choose our portfolio tracker
Compare Sharesight to alternative portfolio trackers and see why 500,000+ investors trust Sharesight for smarter portfolio management and tax reporting.
No rush to buy – Big Tech and banks hold the key
No rush to buy — big tech and banks hold the key. The VIX is rising quietly, signalling a shift in sentiment. Will this be a slow bounce or a longer downtrend?
Investopedia names Sharesight best portfolio tracker for DIY investors
We're proud to share that Investopedia has named Sharesight the Best Portfolio Tracker for DIY Investors in its 2025 review.